The plant in the Santiago region will be able to fill and finish some 50 million doses annually, and should be ready before 2023 Chinese pharmaceutical Sinovac Biotech Ltd which makes one of the ...

Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a formal ...

Sinovac Biotech (SVA) announced that Sinovac has received a formal court order from the Privy Council following the previously announced Privy Council Judgment which ruled, among others, that the ...

BEIJING, February 28, 2025--(BUSINESS WIRE)--Sinovac Biotech Ltd. (NASDAQ:SVA) ("SINOVAC" or the "Company"), a leading provider of biopharmaceutical products in China, today announced that SINOVAC ...

BEIJING — Sinovac Biotech Ltd. (NASDAQ:SVA) (“SINOVAC” or the “Company“), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a ...